Trials / Recruiting
RecruitingNCT05054959
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence
Induction Versus Consolidation Chemotherapy in Total Neoadjuvant Therapy of Localy Advanced Rectal Cancer With High Risk of Recurrence (ICONA Study)
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Institute of Oncology Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to identify the most promising sequence of modalities in total neoadjuvant treatment of localy advanced rectal cancer with high risk of recurrence
Detailed description
International recommendations for the treatment of LARC with a high risk of disease recurrence are inconsistent, regarding TNT. In Germain randomised study more pCR were achieved with consolidation chemotherapy. We will compare our standard approach (induction plus consolidation CT) with consolidation CT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | consolidation chemotherapy | 6 cycles CAPOX after chemoradiotherapy |
| OTHER | induction chemotherapy | 4 cycles CAPOX before and 2 cycles CAPOX after chemoradiotherapy |
Timeline
- Start date
- 2021-06-24
- Primary completion
- 2022-12-31
- Completion
- 2027-12-31
- First posted
- 2021-09-23
- Last updated
- 2021-09-23
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT05054959. Inclusion in this directory is not an endorsement.